SG11202008531RA - Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof - Google Patents
Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses ThereofInfo
- Publication number
- SG11202008531RA SG11202008531RA SG11202008531RA SG11202008531RA SG11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA
- Authority
- SG
- Singapore
- Prior art keywords
- oxazino
- quinazoline
- preparation
- type compound
- quinoline type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810182708 | 2018-03-06 | ||
PCT/CN2019/077028 WO2019170088A1 (zh) | 2018-03-06 | 2019-03-05 | 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202008531RA true SG11202008531RA (en) | 2020-10-29 |
Family
ID=67846907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202008531RA SG11202008531RA (en) | 2018-03-06 | 2019-03-05 | Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof |
Country Status (12)
Country | Link |
---|---|
US (1) | US11548900B2 (pl) |
EP (1) | EP3760633B1 (pl) |
JP (1) | JP7190755B2 (pl) |
KR (1) | KR102526281B1 (pl) |
CN (1) | CN110229171B (pl) |
AU (1) | AU2019230859B2 (pl) |
CA (1) | CA3093323C (pl) |
DK (1) | DK3760633T3 (pl) |
ES (1) | ES2905985T3 (pl) |
PL (1) | PL3760633T3 (pl) |
SG (1) | SG11202008531RA (pl) |
WO (1) | WO2019170088A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023081637A1 (en) | 2021-11-02 | 2023-05-11 | Enliven Therapeutics, Inc. | Fused tetracyclic quinazoline derivatives as inhibitors of erbb2 |
WO2024059558A1 (en) * | 2022-09-13 | 2024-03-21 | Enliven Inc. | Polycyclic quinazolines for inhibition of erbb2 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214690B2 (en) * | 2001-02-23 | 2007-05-08 | Ligand Pharmaceuticals Incorporated | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
CN102382106A (zh) | 2010-08-30 | 2012-03-21 | 黄振华 | 苯胺取代的喹唑啉衍生物 |
CN103965213A (zh) | 2013-02-02 | 2014-08-06 | 江苏奥赛康药业股份有限公司 | 7,8-二氢-6H-[1,4]噁嗪[3,2-g]喹唑啉类衍生物及其制备方法和用途 |
CN104530063B (zh) | 2015-01-13 | 2017-01-18 | 北京赛特明强医药科技有限公司 | 喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用 |
CN110229172B (zh) | 2018-03-06 | 2020-12-25 | 北京赛特明强医药科技有限公司 | 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用 |
-
2019
- 2019-03-05 WO PCT/CN2019/077028 patent/WO2019170088A1/zh unknown
- 2019-03-05 DK DK19764669.8T patent/DK3760633T3/da active
- 2019-03-05 JP JP2020546330A patent/JP7190755B2/ja active Active
- 2019-03-05 CN CN201910162537.0A patent/CN110229171B/zh active Active
- 2019-03-05 KR KR1020207028033A patent/KR102526281B1/ko active IP Right Grant
- 2019-03-05 AU AU2019230859A patent/AU2019230859B2/en active Active
- 2019-03-05 US US16/978,158 patent/US11548900B2/en active Active
- 2019-03-05 PL PL19764669T patent/PL3760633T3/pl unknown
- 2019-03-05 EP EP19764669.8A patent/EP3760633B1/en active Active
- 2019-03-05 SG SG11202008531RA patent/SG11202008531RA/en unknown
- 2019-03-05 ES ES19764669T patent/ES2905985T3/es active Active
- 2019-03-05 CA CA3093323A patent/CA3093323C/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3760633B1 (en) | 2021-12-15 |
JP2021515768A (ja) | 2021-06-24 |
US11548900B2 (en) | 2023-01-10 |
US20210040114A1 (en) | 2021-02-11 |
PL3760633T3 (pl) | 2022-04-19 |
CN110229171A (zh) | 2019-09-13 |
EP3760633A4 (en) | 2021-01-06 |
KR102526281B1 (ko) | 2023-04-27 |
JP7190755B2 (ja) | 2022-12-16 |
WO2019170088A1 (zh) | 2019-09-12 |
DK3760633T3 (da) | 2022-01-31 |
KR20200127223A (ko) | 2020-11-10 |
AU2019230859B2 (en) | 2021-10-21 |
ES2905985T3 (es) | 2022-04-12 |
EP3760633A1 (en) | 2021-01-06 |
CA3093323C (en) | 2022-11-29 |
CA3093323A1 (en) | 2019-09-12 |
CN110229171B (zh) | 2021-03-12 |
AU2019230859A1 (en) | 2020-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202007740TA (en) | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | |
IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
SG11202106706TA (en) | Heterocyclic compound intermediate, preparation method therefor and application thereof | |
IL272089A (en) | Compounds, preparations and methods | |
EP3584239A4 (en) | O-AMINOHETEROARYL-ALKYNYL-CONTAINING COMPOUND, MANUFACTURING METHOD AND USES THEREOF | |
EP3676297A4 (en) | COMPOUNDS, COMPOSITIONS AND PROCESSES | |
ZA201906131B (en) | Herbicidal mixture, composition and method | |
EP3569602A4 (en) | IMIDAZOPYRAZINE COMPOUND, METHOD OF MANUFACTURING THEREFORE AND USE OF IT | |
SG11202007554TA (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
EP3640248A4 (en) | AMINOPYRIMIDINE COMPOUND, PROCESS FOR PREPARATION AND USE | |
SG11202007521PA (en) | Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof | |
EP3715342A4 (en) | COMPONENT CONTAINING FLUOROSULFONYL, INTERMEDIATE THEREOF, RELATED PREPARATION PROCESS AND CORRESPONDING USE | |
SG11202008132UA (en) | Composition, method and use | |
EP3112351A4 (en) | Naphthylamide compound, preparation method and use thereof | |
GB2576614B (en) | Compositions, uses and methods | |
EP3543248A4 (en) | PHOSPHORESCENT COMPLEX OF PtAg2, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF | |
EP3447054A4 (en) | CONNECTION AND MANUFACTURING METHOD THEREFOR, COMPOSITION AND APPLICATION THEREOF | |
GB201804163D0 (en) | Uses, compositions and methods | |
IL282817A (en) | New material, production method, and its use | |
EP3789384A4 (en) | FORMAMIDE COMPOUND, PROCESS FOR PREPARATION AND USE | |
EP3581561A4 (en) | BIARYL COMPOUND, MANUFACTURING METHOD AND USE THEREOF | |
SG11202008531RA (en) | Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof | |
PL3750893T3 (pl) | Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania | |
EP3872065A4 (en) | SULFOBIPHENYL COMPOUND, METHOD OF PRODUCTION THEREOF AND USES THEREOF |